Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Ineffective Erythropoiesis in β-Thalassemia Is Characterized by Increased Iron Absorption Mediated by down Regulation of Hepcidin and up Regulation of Ferroportin.

Sara Gardenghi, PhD, Maria Marongiu, Pedro Ramos, Ella Guy, Laura Breda, PhD, Amy Chadburn, MD, Yifang Liu, Gideon Rechavi, MD, Ninette Amariglio, PhD, E.A. Rachmilewitz, MD, Diedra Wrighting, PhD, Nancy C. Andrews, MD, Maria de Sousa, MD, Patricia Giardina, MD, Robert W. Grady, PhD, Stefano Rivella, PhD

Blood (2006) 108 (11): 1543.

https://doi.org/10.1182/blood.V108.11.1543.1543

Published: 2006

Journal Articles

Urinary Hepcidin Excretion in Patients with Myelodysplastic Syndrome (MDS) and Myelofibrosis (MF).

Asher Winder, MD, Rafi Lefkowitz, Hussam Ghoti, MD, Merav Leiba, MD, Tomas Ganz, MD, PhD, Elizabeta Nemeth, MD, E.A. Rachmilewitz, MD

Blood (2006) 108 (11): 2620.

https://doi.org/10.1182/blood.V108.11.2620.2620

Published: 2006

Journal Articles

Addition of Fresh Frozen Plasma to Rituximab Induces a Major Clinical and Laboratory Response in Patients with Refractory Advanced CLL.

Abraham Klepfish, MD, Amichay Schattner, MD, Ioannis Kotsianidis, MD, E.A. Rachmilewitz, MD

Blood (2006) 108 (11): 4986.

https://doi.org/10.1182/blood.V108.11.4986.4986

Published: 2006

Journal Articles

Retrospective Analysis of Clinical Parameters and Survival Data in Patients with Chronic Lymphocytic Leukemia of Younger Versus Older Age Groups.

Abraham Klepfish, MD, M. Sarid, PhD, M. Basalov, MD, H. Ghoti, MD, E.A. Rachmilewitz, MD

Blood (2005) 106 (11): 5001.

https://doi.org/10.1182/blood.V106.11.5001.5001

Published: 2005

Journal Articles

Successful Induction of a Rapid Improvement of Both Clinical and Laboratory Parameters in a Patient with Advanced CLL by Combining Rituximab with Fresh Frozen Plasma as a Source for Complement. A Novel Therapeutic Approach?.

Abraham Klepfish, MD, H. Ghoti, MD, E.A. Rachmilewitz, MD

Blood (2005) 106 (11): 5030.

https://doi.org/10.1182/blood.V106.11.5030.5030

Published: 2005

NARROW

Ineffective Erythropoiesis in β-Thalassemia Is Characterized by Increased Iron Absorption Mediated by down Regulation of Hepcidin and up Regulation of Ferroportin.

Urinary Hepcidin Excretion in Patients with Myelodysplastic Syndrome (MDS) and Myelofibrosis (MF).

Addition of Fresh Frozen Plasma to Rituximab Induces a Major Clinical and Laboratory Response in Patients with Refractory Advanced CLL.

Retrospective Analysis of Clinical Parameters and Survival Data in Patients with Chronic Lymphocytic Leukemia of Younger Versus Older Age Groups.

Successful Induction of a Rapid Improvement of Both Clinical and Laboratory Parameters in a Patient with Advanced CLL by Combining Rituximab with Fresh Frozen Plasma as a Source for Complement. A Novel Therapeutic Approach?.

Email alerts

ASH Publications

American Society of Hematology

Ineffective Erythropoiesis in β-Thalassemia Is Characterized by Increased Iron Absorption Mediated by down Regulation of Hepcidin and up Regulation of Ferroportin.

Urinary Hepcidin Excretion in Patients with Myelodysplastic Syndrome (MDS) and Myelofibrosis (MF).

Addition of Fresh Frozen Plasma to Rituximab Induces a Major Clinical and Laboratory Response in Patients with Refractory Advanced CLL.

Retrospective Analysis of Clinical Parameters and Survival Data in Patients with Chronic Lymphocytic Leukemia of Younger Versus Older Age Groups.

Successful Induction of a Rapid Improvement of Both Clinical and Laboratory Parameters in a Patient with Advanced CLL by Combining Rituximab with Fresh Frozen Plasma as a Source for Complement. A Novel Therapeutic Approach?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only